Advertisement
Advertisement

BCTX

BCTX logo

BriaCell Therapeutics Corp - New

0.6
USD
-0.0456
-7.06%
Dec 18, 15:44 UTC -5
Closed
...

BriaCell Therapeutics Corp - New Profile

About

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the `BriaVax` vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Info & Links

CEO

William V. Williams

Headquarters

235 15th Street, Suite 300
WEST VANCOUVER, A1 V7T 2X1, CANADA

Industry

Biotechnology

Sector

Health Technology

Website

www.briacell.com

Auditor

MNP LLP

Share holders

--

Employees

18

BriaCell Therapeutics Corp - New Statistics

Valuation Measures

Market Capitalization2

21.71M

Enterprise Value

20.85M

Enterprise Value/EBITDA(ttm)

-0.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

392.44%

Return on Assets(ttm)

-44.65%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-33.25M

Net Income Available to Common(ttm)

-4.79M

Diluted EPS(ttm)

-1.17

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

-88.79%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

36.18M

Dividend Yield

0.00%

Float4

28.31M

% Held by Insiders

21.77%

% Held by Institutions

15.42%

Balance Sheet

Total Cash(mrq)

862.10K

Total Cash Per Share(mrq)

0.02

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.49%

Quick Ratio(mrq)

0.49%

Book Value Per Share(mrq)

-0.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.47

Free Cash Flow(ytd)

-24.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement